Πέμπτη 26 Μαΐου 2022

Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib

alexandrossfakianakis shared this article with you from Inoreader

1-s2.0-S0014482722X00116-cov150h.gif

Publication date: Available online 26 May 2022

Source: Experimental Cell Research

Author(s): Chih-Wei Chen, Nai-Kuei Huang, Yueh-Lun Lee, Chia-Kwung Fan, Yen-Chou Chen, Chin-Wei Liu, Huei-Mei Huang

View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου